Meet Celine Halioua, Loyal Founder

Celine Halioua's Work History

Celine Halioua has a background in neuroscience and health economics, with experience in biotech investing and research. She founded Loyal in 2019 and has been leading its efforts to develop lifespan extension drugs for dogs.

• 2019-01 — Founder & CEO, Loyal
• 2019-02 - 2020-01 — Chief of Staff, The Longevity Fund
• 2018-01 - 2019-01 — Entrepreneur In Residence, The Longevity Fund
• 2017-05 - 2018-02 — Scientific Consultant, Oisín Biotechnologies
• 2015 - 2016 — Researcher: Neuro-oncology, Sanford Burnham Prebys Medical Discovery Institute
• 2014-06 - 2015-05 — Research Assistant - Neuropharmacology, The University of Texas at Austin

Celine Halioua's Education

Celine studied neuroscience and nanobiotechnology at the University of Texas at Austin and Uppsala University. She also attended Oxford University for health economics research and completed a DPhil in Paediatrics.

• The University of Texas at Austin — Bachelor of Science (BSc) in Neuroscience (2013 - 2017)
• Uppsala University — Nanotechnology (2015 - 2016)
• Oxford University — DPhil (incomplete) in Paediatrics (2017 - 2019)

About Loyal

Loyal is a clinical-stage veterinary medicine company developing drugs to extend the healthspan and lifespan of dogs. Backed by decades of aging research, Loyal aims to prevent and delay age-related diseases in pets, with the broader goal of applying these insights to human aging.

Loyal Funding

Loyal has raised over $125 million from investors including Khosla Ventures, Bain Capital, First Round Capital, and Valor Equity Partners.

How to Reach Celine Halioua?

You can reach Celine Halioua at *******@loyalfordogs.com or by calling +1 **********. To get Celine Halioua's contact information and other startup founders like this, sign up for a free account at Anybody.com.